SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paradigm Genetics -- PDGM
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (91)8/25/2005 1:06:38 AM
From: Mike McFarland  Read Replies (1) of 101
 
Something like 350k shares yesterday, I know
that is only $60k, but caught my eye.

Also, insiders who left the company have
let go of some of their shares. For instance,
Gugger sold 97k shares at 27 cents, and
still held 200k shares as of June 1st.
etc etc

Rpt Per : COLATSKY THOMAS J
4 8/19/2005 6/1/2005 People
ICORIA, INC. Rpt Per : GUGGER HEINRICH
4 8/19/2005 6/1/2005 People
ICORIA, INC. Rpt Per : BUZOGANY J BARRY
4 8/19/2005 6/1/2005 People
ICORIA, INC. Rpt Per : FARABAUGH BRETT
4 8/19/2005 6/1/2005

Also, Icoria issued yesterday this PR:
...signed an agreement with Isis Pharmaceuticals to
identify biomarkers of toxicity in animal models. Icoria will
use its metabolomics platform to characterize differences in
biochemical profiles between treated and untreated animal
subjects and to identify those biochemicals that are
specifically affected by treatment. Isis can use this
information to suggest pathways that may be altered by future
drug candidates.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2023 Knight Sac Media.  Data provided by IEX, Alpha Vantage, Coinbase, Binance, Fintel and CityFALCON News